Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Completion of Phase 1 Integration Aligns and Strengthens Gaelic and Athlone Labs
Tuesday, June 09, 2026The first steps in the integration of Irelands sole GMPapproved manufacturers of BetaLactam antibiotics which merged in December through a horizontal acquisition have met corporate objectives for synergy
Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform
Tuesday, June 09, 2026Johnson Johnson NYSE JNJ today announced it has entered into a definitive agreement to acquire Firefly Bio Inc a biotechnology company advancing its proprietary Firelink degrader antibody conjugate DAC platform
Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer
Tuesday, June 09, 2026Zai Lab Limited NASDAQ ZLAB HKEX today announced that Chinas National Medical Products Administration NMPA has approved the Biologics License Application BLA for TIVDAK tisotumab vedotin
FloBiotech Announces Agreement with UCLA Health® to Advance Neurodegenerative Disease Therapeutics
Tuesday, June 09, 2026FloBiotech today announced an agreement with UCLA Health to advance a novel class of therapeutics targeting biologically validated protective pathways in neurodegeneration
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis
Tuesday, June 09, 2026th International Symposium on High Performance Liquid Phase Separations and Related TechniquesWaters Corporation NYSE WAT today announced the launch of the BioResolve Peptide and GTxResolve
USP Publishes Product-Specific Emerging Biologics Standards for Public Comment
Tuesday, June 09, 2026The US Pharmacopeia USP today announced the publication of a set of productspecific biologics emerging standards now available for public comment through the Emerging Standards Platform
Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
Monday, June 08, 2026The European Commission has approved Sarclisa isatuximab subcutaneous SC in combination with standardofcare regimens for the treatment of patients with multiple myeloma MM across all existing
Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia
Monday, June 08, 2026Amphista Therapeutics the Company or Amphista a leader in the discovery and development of next generation targeted protein degradation TPD medicines today announces that the US Food
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®
Monday, June 08, 2026Alvotech NASDAQ ALVO ALVOSDB a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide today announced that the US Food and Drug Administration
DaltonTx launches its drug discovery platform, Dalton, and announces Sygnature Discovery collaboration
Friday, June 05, 2026DaltonTx the intelligence backbone for modern drug discovery connecting AI human expertise and experimental data today announced the launch of Dalton its drug discovery platform
